Clinical chemistry
-
Clinical Trial
Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction.
Validation of whole blood, point-of-care testing devices for monitoring cardiac markers to aid clinicians in ruling in and ruling out myocardial infarction (MI) is necessary for both laboratory and clinical acceptance. ⋯ The First Medical point-of-care device provides cardiac marker assays that can be used by laboratories and clinicians in a variety of hospital settings for ruling in and ruling out MI.